LENZ Therapeutics Statistics
Total Valuation
LENZ has a market cap or net worth of $935.26 million. The enterprise value is $734.04 million.
Important Dates
The last earnings date was Wednesday, November 5, 2025, before market open.
| Earnings Date | Nov 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
LENZ has 31.29 million shares outstanding. The number of shares has increased by 87.55% in one year.
| Current Share Class | 31.29M |
| Shares Outstanding | 31.29M |
| Shares Change (YoY) | +87.55% |
| Shares Change (QoQ) | +1.64% |
| Owned by Insiders (%) | 2.52% |
| Owned by Institutions (%) | 80.90% |
| Float | 20.05M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 50.96 |
| Forward PS | 28.93 |
| PB Ratio | 4.71 |
| P/TBV Ratio | 4.82 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 41.95 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 12.69, with a Debt / Equity ratio of 0.00.
| Current Ratio | 12.69 |
| Quick Ratio | 12.46 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -28.78% and return on invested capital (ROIC) is -20.61%.
| Return on Equity (ROE) | -28.78% |
| Return on Assets (ROA) | -19.52% |
| Return on Invested Capital (ROIC) | -20.61% |
| Return on Capital Employed (ROCE) | -34.93% |
| Revenue Per Employee | $1.59M |
| Profits Per Employee | -$5.35M |
| Employee Count | 11 |
| Asset Turnover | 0.08 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, LENZ has paid $501,000 in taxes.
| Income Tax | 501,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -15.13% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -15.13% |
| 50-Day Moving Average | 35.27 |
| 200-Day Moving Average | 31.02 |
| Relative Strength Index (RSI) | 50.65 |
| Average Volume (20 Days) | 1,299,294 |
Short Selling Information
The latest short interest is 7.23 million, so 23.11% of the outstanding shares have been sold short.
| Short Interest | 7.23M |
| Short Previous Month | 5.66M |
| Short % of Shares Out | 23.11% |
| Short % of Float | 36.05% |
| Short Ratio (days to cover) | 6.25 |
Income Statement
In the last 12 months, LENZ had revenue of $17.50 million and -$58.88 million in losses. Loss per share was -$2.11.
| Revenue | 17.50M |
| Gross Profit | 17.50M |
| Operating Income | -67.90M |
| Pretax Income | -58.38M |
| Net Income | -58.88M |
| EBITDA | -67.70M |
| EBIT | -67.90M |
| Loss Per Share | -$2.11 |
Full Income StatementBalance Sheet
The company has $202.17 million in cash and $954,000 in debt, giving a net cash position of $201.22 million or $6.43 per share.
| Cash & Cash Equivalents | 202.17M |
| Total Debt | 954,000 |
| Net Cash | 201.22M |
| Net Cash Per Share | $6.43 |
| Equity (Book Value) | 193.93M |
| Book Value Per Share | 6.78 |
| Working Capital | 190.68M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$45.22 million and capital expenditures -$938,000, giving a free cash flow of -$46.16 million.
| Operating Cash Flow | -45.22M |
| Capital Expenditures | -938,000 |
| Free Cash Flow | -46.16M |
| FCF Per Share | -$1.48 |
Full Cash Flow StatementMargins
| Gross Margin | 100.00% |
| Operating Margin | -388.00% |
| Pretax Margin | -333.61% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
LENZ does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -87.55% |
| Shareholder Yield | -87.55% |
| Earnings Yield | -6.30% |
| FCF Yield | -4.94% |
Dividend DetailsAnalyst Forecast
The average price target for LENZ is $56.25, which is 88.19% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $56.25 |
| Price Target Difference | 88.19% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
LENZ has an Altman Z-Score of 28.63 and a Piotroski F-Score of 1.
| Altman Z-Score | 28.63 |
| Piotroski F-Score | 1 |
